(Q40137260)

English

An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells

scientific article published on 20 April 2007

In more languages

Statements

scholarly article

1 reference

17 September 2017

An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells (English)

1 reference

17 September 2017

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Herpes simplex virus type 1

1 reference

based on heuristic

inferred from title

author name string

C Y-F Lee

1

1 reference

17 September 2017

L X Bu

2

1 reference

17 September 2017

P S Rennie

3

1 reference

17 September 2017

W W-G Jia

4

1 reference

17 September 2017

publication date

20 April 2007

1 reference

17 September 2017

Cancer Gene Therapy

1 reference

17 September 2017

14

1 reference

17 September 2017

652-660

1 reference

17 September 2017

7

1 reference

17 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701052

0 references

In situ gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

21 January 2018

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Conservative versus radical therapy of prostate cancer: how have recent advances in molecular markers and imaging enhanced our ability to prognosticate risk?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent androgen suppression for prostate cancer: rationale and clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

20-year outcomes following conservative management of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Current strategies in the management of hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

The patient with hormone-refractory prostate cancer: determining who, when, and how to treat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of the development of androgen independence in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Future directions in the treatment of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene therapy for prostate cancer bone metastasis. Gene therapy targeting bone metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene-based therapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral based gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Herpes simplex virus-based vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Intralesional injection of herpes simplex virus 1716 in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-r.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained inhibition of experimental neointimal hyperplasia with a genetically modified herpes simplex virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric herpes simplex virus/adeno-associated virus amplicon vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701052

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7701052

1 reference

17 September 2017

Dimensions Publication ID

0 references

1 reference

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40137260&oldid=1886515689"